Long-term efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: a prospective real-world cohort study in China.

Yuyi Wang; Ruiling Jia; Qin Hu; Xiao Tao; Qi He; Guangying Luo; Qiong Xiong; Zhongyu Zhang; Yujuan Xiao; Yi Liu

doi:10.3389/fimmu.2024.1419164

Long-term efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: a prospective real-world cohort study in China.

Identifier:nobleid.org/w1/20260515/61FBA720

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/61FBA720.svg?ark=w1%2F20260515%2F61FBA720)](https://nobleid.org/work/w1/20260515/61FBA720)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Long-term efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: a prospective real-world cohort study in China.

Identifier:nobleid.org/w1/20260515/61FBA720

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/61FBA720.svg?ark=w1%2F20260515%2F61FBA720)](https://nobleid.org/work/w1/20260515/61FBA720)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work